CDNA Q2 2023 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$889M

Q2 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$70M-12.8% YoY

Gross Profit

$44M63.2% margin

Operating Income

-$28M-39.3% margin

Net Income

-$25M-35.5% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-9.0%

Cash Flow

Operating Cash Flow

-$499,000

Free Cash Flow

-$3M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$515M

Total Liabilities

$110M

Stockholders' Equity

$405M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$81M	-12.8%
Gross Profit	$44M	$53M	-16.3%
Operating Income	-$28M	-$22M	-27.2%
Net Income	-$25M	-$22M	-15.0%

Geographic Segments

UNITED STATES

$53M95%

Europe

$3M5%

Rest Of The World

$145,0000%